Cardiopulmonary Exercise Testing (CPET)
Definition
CPET integrates exercise testing with real-time analysis of respiratory gas volumes and composition (oxygen uptake VO2, carbon dioxide production VCO2, and minute ventilation VE). It provides comprehensive cardiopulmonary functional assessment and is the gold-standard non-invasive tool to distinguish cardiac from pulmonary limitation to exercise — particularly important in HF where COPD frequently coexists.
Key Concepts
VE/VCO2 Slope
- In HF, VE increases disproportionately relative to VCO2 due to V/Q mismatch, increased dead-space fraction (VD/VT), and reduced arterial CO2 tension. (sources/hf-copd-hfreview-2025, rating: high)
- VE/VCO2 slope is one of the most robust prognostic markers in HFrEF — elevated slope (>34–36) reflects ventilatory inefficiency and impaired haemodynamics.
- VE/VCO2 slope does not significantly differ among patients with HF alone, COPD alone, or coexisting HF+COPD — limiting its ability to identify COPD as a comorbidity in HF. (sources/hf-copd-hfreview-2025, rating: high)
VE Intercept (VEint) — Discriminating COPD in HF
- The VE intercept represents the y-intercept of the VE/VCO2 regression line and reflects dead-space (VD) load.
- Higher VD is a primary pathophysiological abnormality in COPD but only a secondary feature in HF.
- A positive VE intercept (VEint ≥2.6–4.07 L/min) has emerged as a promising tool for identifying COPD as an HF comorbidity. (sources/hf-copd-hfreview-2025, rating: high)
- This VEint finding appears consistent across the full HF EF spectrum (HFrEF, HFmrEF, HFpEF). (sources/hf-copd-hfreview-2025, rating: high)
- Unlike the VE/VCO2 slope, the VE intercept captures the dead-space load mechanism that differentiates COPD from pure HF physiology. (sources/hf-copd-hfreview-2025, rating: high)
Clinical Utility in HF-COPD Differential Diagnosis
- CPET is recommended as an additional diagnostic step in stable patients with dyspnoea and confirmed HF to confirm or exclude coexisting COPD. (sources/hf-copd-hfreview-2025, rating: high)
- CPET's strength lies in integrating the two components: a cardiac limitation pattern (reduced peak VO2, steep VE/VCO2 slope, absence of plateau) vs. a pulmonary limitation pattern (flow limitation, reduced breathing reserve, VEint elevation). (sources/hf-copd-hfreview-2025, rating: high)
Peak VO2
- Established prognostic marker in HFrEF; used for transplant listing decisions (typically <12–14 mL/kg/min on beta-blocker therapy).
- In HF+COPD, impaired peak VO2 reflects the combined cardiopulmonary limitation rather than pure cardiac limitation.
Contradictions / Open Questions
- VE intercept thresholds require external validation: The diagnostic range (2.6–4.07 L/min) is based on small studies; prospective validation across the full EF spectrum is needed before clinical implementation. (sources/hf-copd-hfreview-2025, rating: high)
- VE/VCO2 slope not useful for distinguishing COPD in HF: Despite its prognostic value in pure HF, the slope does not differentiate HF from HF+COPD — limiting its diagnostic utility in this context. (sources/hf-copd-hfreview-2025, rating: high)
Connections
- Related to concepts/HF-COPD-Comorbidity — CPET as the primary diagnostic tool to identify COPD in HF
- Related to entities/HFrEF — peak VO2 and VE/VCO2 slope as prognostic markers
- Related to entities/HFpEF — exercise echocardiography and CPET in HFpEF workup
- Related to entities/COPD — exercise limitation and gas exchange abnormalities in COPD